MEDIKAMENTENINJEKTIONSGERÄT
European patent · EP4088764 · In force
Register entry
- Publication number
- EP4088764
- Application number
- EP22172246
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 9, 2022
- Published
- Nov 16, 2022
- Granted
- Jul 2, 2025
- Protection ends at the latest
- May 8, 2042
- Next annual fee due
- May 31, 2027
- IPC classes
- A61M 5/24 (2006.01)A61M 5/315 (2006.01)
- Priority
- IT 202100012020 11.05.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- May 18, 2026
Change
Published in Swissreg on 18.05.2026
- Sep 8, 2025
Agent entered
- Representative
- Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich
Published in Swissreg on 08.09.2025
- Jul 2, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 02.07.2025
Parties
Agent
Inventor
COHEN, Philip Jake
Hendon, London, NW4 1AE, GB
PENROSE, Frances Anne
Ely, Cambridgeshire, CB7 4HJ, GB
DEVINE, Conor
Cambridge, CB4 1DX, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.